Literature DB >> 20424662

Experimental pulmonary granuloma mimicking sarcoidosis induced by Propionibacterium acnes in mice.

Kouji Iio1, Tomoe Ueno Iio, Yuhei Okui, Hirohisa Ichikawa, Yasushi Tanimoto, Nobuaki Miyahara, Arihiko Kanehiro, Mitsune Tanimoto, Yasunari Nakata, Mikio Kataoka.   

Abstract

Propionibacterium acnes has been implicated as an etiologic agent of sarcoidosis since the isolation of this bacterium from sarcoid lesions. We experimentally produced a murine pulmonary granuloma model using P. acnes with several features that simulate sarcoidosis. Mice were sensitized with heat-killed P. acnes and complete Freund's adjuvant and were subsequently challenged with heat-killed P. acnes at 2-week intervals. P. acnes-challenged mice developed epitheloid cell granulomas in the lungs. These mice showed a pulmonary immune response characterized by an increased number of T-lymphocytes, especially CD4+ cells, and the ratio of CD4+/CD8+ in bronchoalveolar lavage (BAL) fluid also increased. Furthermore, significant elevations in both angiotensin-converting enzyme (ACE) serum levels and antibody titers against P. acnes were observed. Mice sensitized with P. acnes without complete Freund's adjuvant were capable of forming pulmonary granulomas, which appeared to be caused by indigenous P. acnes. The genome of P. acnes was found in the lungs, BAL cells, hilar lymph nodes, liver, and spleen in non-sensitized mice, which were thought to be germ-free. These results suggest that the immune response against indigenous P. acnes may play an important role in the pathogenesis of granuloma formation in a murine model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424662     DOI: 10.18926/AMO/32852

Source DB:  PubMed          Journal:  Acta Med Okayama        ISSN: 0386-300X            Impact factor:   0.892


  7 in total

1.  Induction of Pulmonary Granuloma Formation by Propionibacterium acnes Is Regulated by MyD88 and Nox2.

Authors:  Jessica L Werner; Sylvia G Escolero; Jeff T Hewlett; Tim N Mak; Brian P Williams; Yoshinobu Eishi; Gabriel Núñez
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

2.  Transcriptional survey of alveolar macrophages in a murine model of chronic granulomatous inflammation reveals common themes with human sarcoidosis.

Authors:  Arjun Mohan; Anagha Malur; Matthew McPeek; Barbara P Barna; Lynn M Schnapp; Mary Jane Thomassen; Sina A Gharib
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-06       Impact factor: 5.464

3.  PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis.

Authors:  Matthew McPeek; Anagha Malur; Debra A Tokarz; Gina Murray; Barbara P Barna; Mary Jane Thomassen
Journal:  Biochem Biophys Res Commun       Date:  2018-06-15       Impact factor: 3.575

4.  Immune response to Propionibacterium acnes in patients with sarcoidosis--in vivo and in vitro.

Authors:  Jonas Christian Schupp; Sandrine Tchaptchet; Niklas Lützen; Peggy Engelhard; Joachim Müller-Quernheim; Marina A Freudenberg; Antje Prasse
Journal:  BMC Pulm Med       Date:  2015-07-24       Impact factor: 3.317

5.  High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis.

Authors:  Meng-Meng Zhao; Shan-Shan Du; Qiu-Hong Li; Tao Chen; Hui Qiu; Qin Wu; Shan-Shan Chen; Ying Zhou; Yuan Zhang; Yang Hu; Yi-Liang Su; Li Shen; Fen Zhang; Dong Weng; Hui-Ping Li
Journal:  Respir Res       Date:  2017-02-01

6.  Detection of Cutibacterium acnes in granulomas of patients with either hypersensitivity pneumonitis or vasculitis reveals that its presence is not unique for sarcoidosis.

Authors:  Els Beijer; Kees Seldenrijk; Bob Meek; Jan Damen; Marian J R Quanjel; Jan C Grutters; Marcel Veltkamp
Journal:  ERJ Open Res       Date:  2021-05-04

7.  Pulmonary fibrosis in a mouse model of sarcoid granulomatosis induced by booster challenge with Propionibacterium acnes.

Authors:  Dingyuan Jiang; Xiaoxi Huang; Jing Geng; Run Dong; Shuhong Li; Zheng Liu; Chen Wang; Huaping Dai
Journal:  Oncotarget       Date:  2016-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.